Literature DB >> 8613526

Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta.

D A Redford-Badwal1, M L Stover, M Valli, M B McKinstry, D W Rowe.   

Abstract

Osteogenesis imperfecta (OI) is a heritable connective tissue disorder characterized by bone fragility. Most cases of severe OI result from mutations in the coding region of the COL1A1 or COL1A2 genes yielding an abnormal collagen alpha chain. In contrast, many patients with mild OI show evidence of a null allele due to a premature stop mutation in the mutant RNA transcript. We have previously described a null allele arising from a splice donor mutation where the transcript containing the included intron was sequestered in the nucleus. Here we demonstrate that transcripts from null alleles arising from premature stop mutations are also present in the nucleus and absent in the cytoplasm. Using reverse transcriptase-PCR and single-strand conformational polymorphism of COL1A1 mRNA from patients with mild OI, we describe three patients with distinct null producing mutations identified from the mutant transcript within the nuclear compartment. A fourth patient with a Gly--->Arg expressed point mutation exhibits the mutant transcript in both compartments. Defining the distribution of allelic variants of COL1A1 mRNA in the nuclear and cytoplasmic compartments gives further insight into cell biology of OI and provides a strategy for investigating potential causes of a null allele.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1996        PMID: 8613526      PMCID: PMC507150          DOI: 10.1172/JCI118495

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Centrioles and microtubules in Chlorella.

Authors:  A W Atkinson; B E Gunning; P C John; W McCullough
Journal:  Nat New Biol       Date:  1971-11-03

2.  Mapping the cell's nucleus.

Authors:  Y Baskin
Journal:  Science       Date:  1995-06-16       Impact factor: 47.728

3.  Altered relation of two collagen types in osteogenesis imperfecta.

Authors:  B Sykes; M J Francis; R Smith
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

4.  Molecular basis of nanomelia, a heritable chondrodystrophy of chicken.

Authors:  D Primorac; M L Stover; S H Clark; D W Rowe
Journal:  Matrix Biol       Date:  1994-08       Impact factor: 11.583

5.  Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.

Authors:  G S Barsh; K E David; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Posttranscriptional defects in beta-globin messenger RNA metabolism in beta-thalassemia: abnormal accumulation of beta-messenger RNA precursor sequences.

Authors:  E J Benz; A L Scarpa; B L Tonkonow; H A Pearson; A K Ritchey
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

7.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

8.  Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen.

Authors:  M C Willing; S P Deschenes; D A Scott; P H Byers; R L Slayton; S H Pitts; H Arikat; E J Roberts
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

9.  Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.

Authors:  R E Brenner; U Vetter; A M Bollen; M Mörike; D R Eyre
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  11 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; W I Schievink; E Petty; M R Jaff; D Babovic-Vuksanovic; K J Cherry; M Pepin; P H Byers
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

4.  Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations.

Authors:  J Körkkö; L Ala-Kokko; A De Paepe; L Nuytinck; J Earley; D J Prockop
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

5.  Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.

Authors:  I Quack; B Vonderstrass; M Stock; A S Aylsworth; A Becker; L Brueton; P J Lee; F Majewski; J B Mulliken; M Suri; M Zenker; S Mundlos; F Otto
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

6.  Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; J A Goldstein; P H Byers
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

7.  Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains.

Authors:  M C Willing; S P Deschenes; R L Slayton; E J Roberts
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  Identification of a novel COL1A1 frameshift mutation, c.700delG, in a Chinese osteogenesis imperfecta family.

Authors:  Xiran Wang; Yu Pei; Jingtao Dou; Juming Lu; Jian Li; Zhaohui Lv
Journal:  Genet Mol Biol       Date:  2014-03-17       Impact factor: 1.771

10.  A novel variant of osteogenesis imperfecta type IV and low serum phosphorus level caused by a Val94Asp mutation in COL1A1.

Authors:  Qi Yang; Hong Xu; Jinsi Luo; Qinle Zhang; Bobo Xie; Sheng Yi; Xiuliang Rong; Jin Wang; Zailong Qin; Tingting Jiang; Li Lin; Yangjin Zuo; Xin Fan
Journal:  Mol Med Rep       Date:  2018-01-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.